TABLE 1.

Patient Characteristics at Time of TEE

Parameter	Esophageal Varices (n = 79)	No Esophageal Varices (n = 112)	P Value
Age in years	61.0 ± 12.0	61.8 ± 12.7	0.63
Male	48 (60.8)	76 (67.9)	0.36
Race
Caucasian	71 (89.9)	104 (92.9)	0.60
Black	5 (6.3)	4 (3.6)	0.49
Asian	1 (1.3)	2 (1.8)	1.00
Other	1 (1.3)	1 (0.9)	1.00
Unknown	1 (1.3)	1 (0.9)	1.00
Cirrhosis etiology*
Alcohol	25 (31.7)	47 (42.0)	0.17
Nonalcoholic steatohepatitis	26 (32.9)	23 (20.5)	0.06
Hepatitis C virus	25 (31.7)	25 (22.3)	0.18
Cardiac	12 (15.2)	16 (14.3)	1.00
Other	12 (15.2)	16 (14.3)	1.00
Any liver decompensation	42 (53.2)	31 (27.7)	0.0005
Hemodialysis	9 (11.4)	6 (5.4)	0.17
Nonselective beta‐blocker therapy	16 (20.3)	10 (8.9)	0.03
Large esophageal varices †	24 (30.0)	—
Days between upper endoscopy and TEE	225.7 ± 308.1	300.4 ± 337.6	0.12
TEE performed as inpatient	70 (88.6)	96 (85.7)	0.67
TEE performed intra‐operatively	32 (40.5)	34 (30.4)	0.17
Therapeutic TEE	36 (45.6)	43 (38.4)	0.37
Antiplatelet agent within 7 days before TEE	25 (31.7)	38 (33.9)	0.76
Anticoagulation within 7 days before TEE	24 (30.4)	37 (33.0)	0.75
Hemoglobin ‡ (g/dL)	10.4 ± 2.3	11.0 ± 2.7	0.12
Platelet count ‡ (109/L)	107.7 ± 50.6	152.2 ± 83.0	<0.0001
INR ‡	1.7 ± 0.7	1.6 ± 0.6	0.12
Serum bilirubin ‡ (mg/dL)	3.8 ± 7.6	2.8 ± 5.6	0.30
Serum creatinine ‡ (mg/dL)	1.7 ± 1.4	1.4 ± 1.5	0.16
Serum sodium ‡ (mEq/L)	136.0 ± 4.4	138.0 ± 4.6	0.004
MELD‐Na score ‡	21.3 ± 7.8	16.4 ± 7.5	<0.0001

Continuous variables are reported as mean ± SD; categorical variables are reported as n (%).

^*Total exceeds group size due to presence of concurrent cirrhosis etiologies.

^†Upper endoscopy performed within 4 years of TEE.

^‡Laboratory variables reflect nearest value prior to TEE.